Trident Lifeline EGM notice details ₹58 crore preferential issue

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Trident Lifeline schedules EGM on Oct 27 to approve ₹58 crore preferential issue
  • Equity shares of ₹41.14 crore offered to public category investors only
  • Warrants worth ₹16.84 crore issued to promoters and select public investors
  • Issue price fixed at ₹336.60 per unit based on 90-day VWAP floor price
powered bylight_fuzz_icon
52239101

*this image is generated using AI for illustrative purposes only.

Trident Lifeline Limited has issued the formal notice for its Extraordinary General Meeting (EGM), scheduled for October 27, 2026, to seek shareholder approval for a ₹58 crore preferential issue. The proposal involves issuing equity shares and fully convertible warrants at ₹336.60 per unit to specific public and promoter group investors.

The board meeting on October 5, 2026, approved the issuance of 12,22,200 equity shares and up to 5,00,400 fully convertible warrants. This capital infusion is intended to meet working capital requirements, repay secured borrowings, and fund business expansion. The issue is structured under Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Details of the preferential issue

The issuance is split into two components with distinct investor categories:

  1. Equity Shares: 12,22,200 shares with a face value of ₹10 each, aggregating to ₹41.14 crore. These will be issued exclusively to public category investors (non-promoters). The relevant date for price determination is September 25, 2026.
  2. Equity Warrants: Up to 5,00,400 warrants, each convertible into one fully paid-up equity share. The total consideration is capped at ₹16.84 crore. These are offered to promoter/promoter group members and select non-promoter/public investors.

Investors must pay 25% of the warrant price at subscription, with the remaining 75% due upon exercise within 18 months from the date of allotment. The floor price was calculated based on the volume-weighted average price over the preceding 90 trading days on the BSE SME platform, resulting in a minimum price of ₹336.57. The final issue price of ₹336.60 includes a premium of ₹326.60 per share.

Shareholding pattern impact

Following the full conversion of warrants and allotment of shares, the shareholding pattern is expected to shift as follows:

Category Pre-Issue Shares Pre-Issue % Post-Issue Shares Post-Issue %
Promoters & Promoters' Group 74,68,400 62.46% 80,11,400 56.35%
Public 44,88,600 37.54% 62,04,600 43.65%
Total 1,19,57,000 100.00% 1,42,16,000 100.00%

Note: Post-issue figures assume full subscription and conversion of all warrants.

Key allottees and pricing basis

The equity share component is directed solely at non-promoter entities and individuals. Notable allottees include India Equity Fund 1 (3,04,200 shares), Motherbox Technologies Private Limited (1,48,200 shares), and Bhagwan Singh Chodhary HUF (1,03,800 shares). The warrant component sees participation from promoters, including Hardik Jigishkumar Desai and his family trust, as well as non-promoter individuals like Ashish Anandsingh Bafna.

The valuation report supporting the price was issued by Mr. Anurag Singal, a registered valuer, on October 5, 2026. The company confirmed that no change in management or control will occur as a result of this preferential issue.

Board meeting outcomes and next steps

In addition to approving the fund-raising plan, the board took several procedural steps:

  • Approved the alteration of Articles of Association to include provisions for issuing warrants.
  • Scheduled an Extraordinary General Meeting (EGM) for October 27, 2026, via video conferencing to seek shareholder approval.
  • Appointed National Securities Depository Limited (NSDL) as the remote e-voting agency.
  • Designated CS Mebul Amareliya as the scrutinizer for the e-voting process.

Remote e-voting facilities are open from October 24, 2026, to October 26, 2026. The trading window for dealing in securities remains closed effective September 29, 2026, and will reopen 48 hours after the conclusion of the board meeting.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0MKA01014/ef3d1a93-d791-4016-b21b-10e97dd9eb0c.pdf

Historical Stock Returns for Trident Lifeline

1 Day5 Days1 Month6 Months1 Year5 Years
+2.85%-0.81%+8.25%+61.87%+28.77%+268.93%

How will the repayment of secured borrowings using the preferential issue proceeds impact Trident Lifeline's future debt-to-equity ratio and interest coverage metrics?

What specific business expansion projects or capital expenditure plans will be funded by the remaining portion of the ₹58 crore capital infusion?

How might the dilution of promoter shareholding from 62.46% to 56.35% influence corporate governance dynamics and minority shareholder rights in subsequent board decisions?

Trident Lifeline hosts analyst meet in Surat, discusses growth plans

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Trident Lifeline Limited held an analyst meet on October 1, 2026
  • Meeting occurred in physical mode at Vapi and Surat venues
  • Management discussed growth plans and manufacturing facilities
  • No Unpublished Price Sensitive Information was disclosed
powered bylight_fuzz_icon
52410644

*this image is generated using AI for illustrative purposes only.

Trident Lifeline Limited hosted a group of analysts and investors on October 1, 2026, for a physical meeting held across Vapi and Surat. The event facilitated direct interaction between the company's management and key market participants regarding business operations and industry trends.

The meeting took place from 10:00 am to 6:00 pm. Attendees included representatives from Mittal Analytics Pvt Ltd, Mavira Asset Management, Vivog Commercial, Seven Islands PMS, and Trinetra Asset Managers. Other participating firms were Mission Street Holdings, Mastergrowth369 Asset Managers, Ambit Wealth, Genuity Capital, and Eklavyainvesco Family Office.

Meeting participants and agenda

Additional attendees included Sequent Investments, Elios Financial Services, Polar Ventures LLP, Bimal Panchal & Associates, DevGanga Enterprise, Shreeji Ventures, AH Capital, AB & Associates, and PFA & Associates LLP.

During the session, management provided insights into the company’s financial performance and outlined its future growth plans. The group also visited the company’s manufacturing facilities to gain a better understanding of operational capabilities.

Regulatory compliance and disclosure

The company confirmed that no Unpublished Price Sensitive Information (UPSI) was shared or discussed during the meeting. All matters addressed were limited to information already available in the public domain or previously disclosed by Trident Lifeline. This disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Trident Lifeline

1 Day5 Days1 Month6 Months1 Year5 Years
+2.85%-0.81%+8.25%+61.87%+28.77%+268.93%

How will the specific growth plans outlined during the October 2026 investor meet influence Trident Lifeline's capital expenditure strategy for the upcoming fiscal year?

What impact might the expanded analyst coverage from firms like Ambit Wealth and Genuity Capital have on Trident Lifeline's institutional holding patterns in Q4 2026?

Did the facility visits to Vapi and Surat reveal any capacity expansion timelines that could affect the company's ability to meet projected demand?

More News on Trident Lifeline

1 Year Returns:+28.77%